Reports and Intelligence: RNA Based Therapeutics Market - Size, Share, Global Trends, Company Profiles, Demand 2013-2020 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Reports and Intelligence: RNA Based Therapeutics Market - Size, Share, Global Trends, Company Profiles, Demand 2013-2020

Description:

RNA based therapeutics has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions. Despite being in the clinical research phase, the RNA based therapeutics is been explored as a promising treatment option for the diseases which are difficult to treat. Detailed report at: – PowerPoint PPT presentation

Number of Views:26

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Reports and Intelligence: RNA Based Therapeutics Market - Size, Share, Global Trends, Company Profiles, Demand 2013-2020


1

Global RNA Based Therapeutics Market
(Technology, Application, End Users and
Geography) - Size, Share, Global Trends, Company
Profiles, Demand, Insights, Analysis, Research,
Report, Opportunities, Segmentation and Forecast,
2013 - 2020

No of pages 140
Publish Date September 2014
2
Description


RNA based therapeutics has garnered significant
attention in the recent years due to its
potential to treat variety of chronic diseases
such as cancer, diabetes, AIDS, Tuberculosis and
certain cardiovascular conditions. Despite being
in the clinical research phase, the RNA based
therapeutics is been explored as a promising
treatment option for the diseases which are
difficult to treat. Development of this
therapeutics is based on promising technologies
such as RNA interference technology (RNAi),
antisense technology and SMaRT technology. RNAi
technology and antisense technology together are
gaining prominence in the research industry, as
these technologies provide base sequence to
develop RNA drugs. RNAi technology works by
causing destruction of specific mRNA molecules
whereas, antisense technology works by
synthesizing strand of RNA from known gene
sequence. These newly synthesized RNA strands
then itself binds to mRNA and make mRNA inactive.
Gene silencing potential of RNA based
therapeutics is the primary driver for the growth
of this market. The other drivers include target
specificity and selectivity of RNAi therapeutics,
more intense product focus versus platform
technologies and virtual drug development models
that enable companies to reduce the research
cost.
3
Description


RNA based therapeutics market is segmented into
technology, application, end-users and geography.
Technology segment is further categorized as
enabling technologies and enabled technologies.
The segment of enabling technologies comprises of
Microarrays, Labeling, Purification, Linear
amplification, qRT-PCR and Inhibition whereas,
enabled technologies includes RNA interference
technology (RNAi) and RNA antisense technology.
Enabled technologies account for largest market
share due to their potential use in therapeutics.
The market for RNA based therapeutics is
dominated by RNA interference technology as
numerous companies have exhibited their interest
to develop the RNA drugs using RNAi technology.
RNA based therapeutics have wide applications
covering variety of chronic conditions such as
Cardiovascular, Kidney Diseases, Oncology,
Infectious diseases, Metabolic disorders and
Others. The pipeline research is concentrated
towards oncology and infectious diseases due to
their high prevalence and failure of existing
treatment to effectively treat these conditions.
The end user market is segmented into research,
therapeutics and diagnostics.
4
Key  Benefits

  • An in-depth analysis of research and clinical
    developments within RNA based therapeutics market
    is provided and light is shed on market dynamics
    that would prove crucial in understanding the
    market
  • Quantitative analysis of the current market and
    estimations through 2013-2020 would assist
    strategists to design business strategies to
    capitalize on the prevailing opportunities in the
    market
  • Competitive structure of RNA based therapeutics
    market is analyzed through Porters Five Forces
    model and provides in-depth understanding of the
    influencing factors for commercialization of RNA
    therapeutics
  • Detailed study of the strategies of key leaders,
    partnerships, acquisitions and clinical trials in
    the RNA based therapeutics market would be
    informative for professionals in the corporate
    sector
  • Pin-point analysis of geographic segments would
    assist in identification of most profitable
    segments to capitalize on
  • Detailed Report at http//www.reportsandintellige
    nce.com/RNA-based-therapeutics-market

5
Table Of Content

  • Introduction
  • Executive Summary
  • Market Overview
  • Global RNA Based Therapeutics  Market By
    Technologies, 2013-2020, Million
  • Global RNA Based Therapeutics Market By
    Applications, 2013-2020, Million
  • Global RNA Based Therapeutics Market By End
    Users, 2013-2020, Million
  • Get full TOC at http//www.reportsandintelligence
    .com/RNA-based-therapeutics-market/table-of-conten
    ts

6

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/RNA-based-th
erapeutics-market
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555 E-MAIL sales_at_reportsandintellig
ence.com
About PowerShow.com